Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (301-310 of 341) with videos related to

Pageof 35
Sort By:
Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.
Journal of Crohn'S & Colitis|October 12, 2014
European evidence based consensus on surgery for ulcerative colitisTom Øresland, Willem A Bemelman, Gianluca M Sampietro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 29, 2026
Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJurij Hanzel, Yuhong Yuan, Shane W Goodwin, et al.
Inflammatory Bowel Diseases|January 21, 2017
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling OutcomesFernando Magro, Cláudia C Dias, Rosa Coelho, et al.
Inflammatory Bowel Diseases|May 11, 2012
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II)Cecília Durães, José C Machado, Francisco Portela, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2020
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After BiopsyFernando Magro, Catarina Alves, Joanne Lopes, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Journal of Crohn'S & Colitis|December 9, 2016
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Pageof 35

Showing results (301-310 of 341) with videos related to

Sort By:
Pageof 35
Therapeutic Advances in Gastroenterology|November 3, 2016
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assaysJoana Afonso, Susana Lopes, Raquel Gonçalves, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 19, 2016
Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort StudyGionata Fiorino, Pablo Navarro Cortes, Pierre Ellul, et al.
Journal of Crohn'S & Colitis|October 12, 2014
European evidence based consensus on surgery for ulcerative colitisTom Øresland, Willem A Bemelman, Gianluca M Sampietro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 29, 2026
Patient-reported Outcomes in Clinical Trials of Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJurij Hanzel, Yuhong Yuan, Shane W Goodwin, et al.
Inflammatory Bowel Diseases|January 21, 2017
Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling OutcomesFernando Magro, Cláudia C Dias, Rosa Coelho, et al.
Inflammatory Bowel Diseases|May 11, 2012
Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II)Cecília Durães, José C Machado, Francisco Portela, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 13, 2020
Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After BiopsyFernando Magro, Catarina Alves, Joanne Lopes, et al.
United European Gastroenterology Journal|December 28, 2022
Transmural remission improves clinical outcomes up to 5 years in Crohn's diseaseSamuel Raimundo Fernandes, Juliana Serrazina, Inês Ayala Botto, et al.
Journal of Crohn'S & Colitis|December 9, 2016
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Journal of Crohn'S & Colitis|September 30, 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsCláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, et al.
Pageof 35